Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 2
2014 5
2015 3
2016 5
2017 6
2018 1
2019 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Results by year
Filters applied: . Clear all
Page 1
Kidney Complications of Immune Checkpoint Inhibitors: A Review.
Shingarev R, Glezerman IG. Shingarev R, et al. Among authors: glezerman ig. Am J Kidney Dis. 2019 Oct;74(4):529-537. doi: 10.1053/j.ajkd.2019.03.433. Epub 2019 Jul 11. Am J Kidney Dis. 2019. PMID: 31303350 Free PMC article. Review.
Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.
Wanchoo R, Abudayyeh A, Doshi M, Edeani A, Glezerman IG, Monga D, Rosner M, Jhaveri KD. Wanchoo R, et al. Among authors: glezerman ig. Clin J Am Soc Nephrol. 2017 Jan 6;12(1):176-189. doi: 10.2215/CJN.06100616. Epub 2016 Sep 21. Clin J Am Soc Nephrol. 2017. PMID: 27654928 Free PMC article. Review.
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.
Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer JR, Le DT, Lipson EJ, Glezerman IG, Wolchok J, Cornell LD, Feldman P, Stokes MB, Zapata SA, Hodi FS, Ott PA, Yamashita M, Leaf DE. Cortazar FB, et al. Among authors: glezerman ig. Kidney Int. 2016 Sep;90(3):638-47. doi: 10.1016/j.kint.2016.04.008. Epub 2016 Jun 7. Kidney Int. 2016. PMID: 27282937 Free PMC article.
Denosumab for treatment of hypercalcemia of malignancy.
Hu MI, Glezerman IG, Leboulleux S, Insogna K, Gucalp R, Misiorowski W, Yu B, Zorsky P, Tosi D, Bessudo A, Jaccard A, Tonini G, Ying W, Braun A, Jain RK. Hu MI, et al. Among authors: glezerman ig. J Clin Endocrinol Metab. 2014 Sep;99(9):3144-52. doi: 10.1210/jc.2014-1001. Epub 2014 Jun 10. J Clin Endocrinol Metab. 2014. PMID: 24915117 Free PMC article. Clinical Trial.
Hypercalcemia of malignancy and new treatment options.
Sternlicht H, Glezerman IG. Sternlicht H, et al. Among authors: glezerman ig. Ther Clin Risk Manag. 2015 Dec 4;11:1779-88. doi: 10.2147/TCRM.S83681. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 26675713 Free PMC article. Review.
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, Murakami N, Herrmann SM, Manohar S, Shirali AC, Kitchlu A, Shirazian S, Assal A, Vijayan A, Renaghan AD, Ortiz-Melo DI, Rangarajan S, Malik AB, Hogan JJ, Dinh AR, Shin DS, Marrone KA, Mithani Z, Johnson DB, Hosseini A, Uprety D, Sharma S, Gupta S, Reynolds KL, Sise ME, Leaf DE. Cortazar FB, et al. Among authors: glezerman ig. J Am Soc Nephrol. 2020 Feb;31(2):435-446. doi: 10.1681/ASN.2019070676. Epub 2020 Jan 2. J Am Soc Nephrol. 2020. PMID: 31896554 Free PMC article.
Response.
Glezerman IG, Hu MI, Jain RK. Glezerman IG, et al. J Natl Cancer Inst. 2014 Jun 6;106(7):dju138. doi: 10.1093/jnci/dju138. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 24906399 No abstract available.
Kidney Toxicities Associated With Novel Cancer Therapies.
Lefebvre J, Glezerman IG. Lefebvre J, et al. Among authors: glezerman ig. Adv Chronic Kidney Dis. 2017 Jul;24(4):233-240. doi: 10.1053/j.ackd.2017.05.006. Adv Chronic Kidney Dis. 2017. PMID: 28778363 Review.
Long-Term Renal Outcomes after Cisplatin Treatment.
Latcha S, Jaimes EA, Patil S, Glezerman IG, Mehta S, Flombaum CD. Latcha S, et al. Among authors: glezerman ig. Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1173-9. doi: 10.2215/CJN.08070715. Epub 2016 Apr 12. Clin J Am Soc Nephrol. 2016. PMID: 27073199 Free PMC article.
26 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page